Monolith Archives - NanoTemper Technologies

NanoTemper Technologies announces Monolith X with breakthrough Spectral Shift technology, enabling binding affinity measurements where other methods fail 

September 21, 2022

NanoTemper Technologies introduced Monolith X, adding breakthrough Spectral Shift technology to their top-selling Monolith product…

March 31, 2022

Targeted Protein Degradation (TPD), a relatively new therapeutic approach, is making waves by targeting otherwise…

October 7, 2021

Neurodegenerative diseases (ND) and cancer are the two major targets in the pipelines of companies…

September 15, 2021

With PROTACs currently in the clinical and preclinical stages, they are making exciting progress towards…

July 1, 2021

NanoTemper’s newest Monolith instrument has been awarded the Red Dot Award, an internationally recognized seal…

April 21, 2021

There has been considerable and promising development in the field of targeted protein degradation (TPD)…

April 15, 2021

NanoTemper’s newest Monolith instrument has been awarded the globally renowned iF DESIGN AWARD 2021. User-friendly…

March 29, 2021

Protein degraders are getting a lot of attention for being a new and promising modality…

February 25, 2021

Update: See what 2022 conferences you should watch for Conferences in 2021 will gather scientists…